已发表的部分文献: 标题:Endometriosis is characterized by a distinct pattern of histone 3 and histone 4 lysine modifications.作者:Monteiro JB, Colón-DÃaz M, GarcÃa M, Gutierrez S, Colón M, Seto E, Laboy J, Flores I;杂志名称:Reprod Sci 标题:Effects of Wutou Decoction on DNA Methylation and Histone Modifications in Rats with Collagen-Induced Arthritis作者:Liu Y, Wen C, Chen Z, Wang Y, Huang Y, Hu Y, Tu S;杂志名称:Evid. Based Complement. Alternat. Med. 标题:In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1, and NSD3/WHSC1L.作者:Morishita M, Mevius D, di Luccio E;杂志名称:BMC Struct Biol 标题:RIZ1 and histone methylation status in pituitary adenomas.作者:Xue Y, Chen R, Du W, Yang F, Wei X;杂志名称:Tumour Biol 标题:Decreased expression of EZH2 in granulosa cells contributes to endometriosis-associated infertility by targeting IL-1R2.作者:Lin X, Tong X, Zhang Y, Gu W, Huang Q, Zhang Y, Zhuo F, Zhao F, Jin X, Li C, Huang D, Zhang S, Dai Y;杂志名称:Endocrinology Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。